In a concise study, it was proved that treatment of Mononuclear Cells (MNCs) with copper‐based nanoparticles, induces TGF‐β/SMAD pathway and subsequent elevation of ECM compounds occurs, leading to liver fibrosis. Here, TGFB1 is linked to Hepatic fibrosis.